Ethacrynic Acid 25 MG Oral Tablet

INDICATIONS AND USAGE Ethacrynic acid tablets is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynic acid sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable.

alvogen, inc.

FDA Reported Adverse Reactions
`[1] chronic kidney disease` `[2] nausea` `[3] fatigue` `[4] diarrhoea` `[5] acute kidney injury` `[6] dyspnoea` `[7] drug ineffective` `[8] off label use` `[9] pain` `[10] headache`

3 years ago

OVAL WHITE F27 25

HOW SUPPLIED Ethacrynic acid tablets, USP, 25 mg, are white scored capsule shaped tablet, debossed "F27" on left side of the score and "25" on the right. They are supplied as follows: NDC 47781-497-01 in bottles of 100. Storage Store in a tightly closed container at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

More pills like OVAL F27 25

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Ethacrynic Acid 25 MG Oral Tablet

FDA Reported Adverse Reactions [1] chronic kidney disease [2] nausea [3] fatigue [4] diarrhoea [5] acute kidney injury [6] dyspnoea [7] drug ineffective [8] off label use [9] pain [10] headache

OVAL WHITE F27 25

More pills like OVAL F27 25

FDA Reported Adverse Reactions
`[1] chronic kidney disease` `[2] nausea` `[3] fatigue` `[4] diarrhoea` `[5] acute kidney injury` `[6] dyspnoea` `[7] drug ineffective` `[8] off label use` `[9] pain` `[10] headache`